Mangalam Drugs and Organics is gearing up production of Hydroxrychloroquine Sulphate (HCQS) and Chloroquine Phosphate (CQP) APIs to meet the demand in case these APIs are approved for treatment of patients affected by Coronavirus Disease (COVID-19) by regulatory authorities and safeguard lives of affected in these challenging times.
Mangalam Drugs and Organics manufactures chemicals such as API perfumery, disperse dye intermediates, bulk drugs and bulk drugs intermediates at VAPI-Gujarat State. It has a multi-product manufacturing facility and a in-house Research and Development (R&D) Base.
